SCHEMBL24512752

SCHEMBL24512752

O=Cc1ccc(Oc2ccc(S(=O)(=O)C(F)(F)F)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPRZ1 P23471 1/20 0.50
PARP10 Q53GL7 1/20 0.45
PARP3 Q9Y6F1 1/20 0.45
STS P08842 1/20 0.44
PTPN1 P18031 2/20 0.43
ALDH1A1 P00352 6/20 0.42
SMN1; SMN2 Q16637 5/20 0.42
LMNA P02545 4/20 0.42
KDM4E B2RXH2 2/20 0.42
EPAS1 Q99814 3/20 0.42
HTT P42858 4/20 0.42
MAPK1 P28482 2/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TP53 P04637 1/20 0.42
MAPT P10636 1/20 0.42
TSHR P16473 1/20 0.42
XBP1 P17861 1/20 0.42
MDM2 Q00987 1/20 0.42
HSD17B10 Q99714 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1940828 0.89 LMNA (0.47) PTPRZ1STSALDH1A1SMN1; SMN2LMNA
SCHEMBL11507063 0.87 PTPRZ1 (0.61) PTPRZ1PTPN1ALDH1A1SMN1; SMN2LMNA
SCHEMBL8941529 0.82 PTPRZ1 (0.56) PTPRZ1PTPN1ALDH1A1SMN1; SMN2LMNA
SCHEMBL6854376 0.80 STS (0.52) PARP10PARP3STSALDH1A1SMN1; SMN2
SCHEMBL8941641 0.79 PTPRZ1 (0.50) PTPRZ1PTPN1ALDH1A1SMN1; SMN2LMNA
SCHEMBL11060588 0.79 PTPRZ1 (0.53) PTPRZ1PARP10PTPN1ALDH1A1LMNA
SCHEMBL8941500 0.77 PTPRZ1 (0.51) PTPRZ1PTPN1ALDH1A1SMN1; SMN2EPAS1
SCHEMBL8941541 0.77 PTPRZ1 (0.51) PTPRZ1PTPN1ALDH1A1SMN1; SMN2EPAS1
SCHEMBL5050902 0.77 PARP10 (0.65) PARP10PARP3STSALDH1A1SMN1; SMN2
SCHEMBL1663469 0.77 PARP10 (0.65) PARP10PARP3STSALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2022-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220185815-A1 PYRROLOPYRAZOLE DERIVATIVE PTDSS1, PTDSS2, SMPD1 PTPRZ1 458/4885PARP10 356/4885PARP3 854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.